Immediate Impact
3 by Nobel laureates 24 from Science/Nature 68 standout
Citing Papers
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia
2024 StandoutNature
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
2022 StandoutScience
Works of Françoise Smets being referenced
Recombinant gp350 Vaccine for Infectious Mononucleosis: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of an Epstein‐Barr Virus Vaccine in Healthy Young Adults
2007
PATIENTS AT RISK FOR DEVELOPMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: PLASMA VERSUS PERIPHERAL BLOOD MONONUCLEAR CELLS AS MATERIAL FOR QUANTIFICATION OF EPSTEIN-BARR VIRAL LOAD BY USING REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION1,2
2001
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Françoise Smets | 1222 | 1085 | 814 | 72 | 2.9k | |
| K. A. Porter | 1254 | 791 | 1248 | 45 | 3.6k | |
| Stefan J. Urbanski | 944 | 725 | 1032 | 112 | 3.6k | |
| D. G. D. Wight | 1425 | 1116 | 247 | 70 | 2.8k | |
| Inga Hägerstrand | 956 | 1028 | 719 | 126 | 2.9k | |
| Dhanpat Jain | 1269 | 1034 | 968 | 137 | 4.1k | |
| F Potet | 1484 | 516 | 576 | 116 | 3.1k | |
| Elie‐Serge Zafrani | 576 | 1404 | 522 | 53 | 2.8k | |
| Joel E. Haas | 1311 | 766 | 639 | 66 | 3.7k | |
| Klaus J. Lewin | 2527 | 383 | 1058 | 102 | 4.9k | |
| Fiona Graeme‐Cook | 1116 | 476 | 704 | 86 | 2.9k |
All Works
Loading papers...